Global Autoimmune Disease Diagnostics Market

The Global Autoimmune Disease Diagnostics Market was valued at US$ XX billion in 2016 and is expected to grow at around XX% CAGR to reach nearly US$ XX billion by 2022. Autoimmune diseases are diseases in which the patient's immune system starts attacking the normal and healthy cells of the patient. The autoimmune disease diagnostics market consists of devices and procedures that help to diagnose whether the patient is suffering from an autoimmune disease and also the type of the autoimmune disease. Some of the different diagnostic methods used are autoantibody tests, complete blood count, C-reactive protein, antinuclear antibody tests, etc. Factors like growing incidence of autoimmune diseases and adoption of new technology are driving the growth of the market.

End Users

The end users of the autoimmune disease diagnostics market are mainly hospitals, diagnostic centres and research laboratories. Availability of different types of products has helped expand the end user base of the market.

Market Dynamics

The rising prevalence of autoimmune diseases is the main growth factor for the autoimmune disease diagnostics market. Improved access to healthcare has enabled greater number of people to avail of these products, hence expanding the market. Investment in research and adoption of new technology has helped in the development of innovative diagnostic methods with high accuracy and efficiency. Introduction of such products is expected to fuel further growth of the market. Another growth factor for the market is the increasing population of geriatric individuals who are naturally at a higher risk of suffering from autoimmune diseases. Support from the government in the form of subsidies may also help in the growth of the market.

The market also faces some restraints in the form of relatively low awareness about autoimmune diseases and high costs of the diagnostic processes. Low availability of skilled technicians and high incidence of false reports are other threats to the market. Another restraint is the high time required to obtain the results of the diagnostic processes. Hence, companies need to come up with more efficient and accurate diagnostic products to take advantage of the growth of the market.

Market Segmentation

The global autoimmune disease diagnostics market can be segmented on the basis of testing method, disease being targeted, end users, and geography. On the basis of testing method, the market can be segmented as autoantibody tests, complete blood count, C-reactive protein, antinuclear antibody tests, comprehensive metabolic panel, urinalysis, and others. On the basis of disease targeted, the market can be segmented as Rheumatoid arthritis, chronic lymphocytic thyroiditis, Type 1 diabetes, Graves' disease, Systemic Lupus Erythematosus, etc. Based on end users, the market is segmented as hospitals, diagnostic centres and research laboratories.

Regional/Geographic Analysis

Geographically, the Autoimmune Disease Diagnostics market can be divided into North America, Europe, Asia-Pacific (APAC), and Latin America, Middle East and Africa (LAMEA) regions. Currently North America accounts for the largest share of the market. However, there is considerable growth potential in the APAC region due to growing geriatric population and prevalence of diseases.

Key Players

Some of the key players in the global autoimmune disease diagnostics market are SQI Diagnostics, Beckman Coulter, Inc., Abott Laboratories, Inova Diagnostics, Siemens Healthineers, and others.

Report Contents:

> Market segments

> Market Drivers, Restraints and Opportunities

> Market Size & Forecast 2016 to 2022

> Supply & Demand Value Chain

> Market - Current Trends

> Competition & Major Companies

> Technology and R&D Status

> Porters Five Force Analysis

> Strategic and Critical Success Factor Analysis of Key Players

Regional Analysis:

> North America

>> US and Canada

> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Report Highlights:

> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

> Consumer and Pricing Analysis

> Market dynamics of the industry

> Market Segmentation

> Estimated Market Sizing in terms of volume and value

> Recent trends in Market and impact

> Research Status and Technology Overview

> Extensive Industry Structure Coverage